Advertisement
Product › Details
DCE Platform® (deuterated chemical entity platform)
Next higher product group | drug development technology_o | |
Status | 2022-11-01 existent | |
Organisation | Concert Pharmaceuticals Inc. (Nasdaq: CNCE) | |
Group | Sun Pharmaceutical (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for drug development technology_o
- [1] Avacta Group plc. (1/8/20). "Press Release: Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture". Cambridge & Seoul....
- [2] Avacta Group plc. (11/13/19). "Press Release: LG Chem Life Sciences Expands Partnership with Avacta"....
- [3] Avacta Group plc. (10/18/19). "Press Release: Proposed Placing and Subscription to Raise up to £9 Million and Notice of General Meeting"....
- [4] Pharnext S.A.. (10/19/17). "Press Release: First-Half 2017". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top